MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 9071-9080 Newer>
Chemistry World
April 9, 2015
Emma Stoye
BMS invests in gene therapy Bristol-Myers Squibb has agreed to invest over $100 million in Netherlands-based biotechnology company uniQure, which specializes in gene therapies for cardiovascular diseases. mark for My Articles 17 similar articles
Chemistry World
April 2, 2015
Emma Stoye
Horizon to acquire orphan drugs in $1.1bn Hyperion takeover Horizon will gain two rare disease drugs: Ravicti (glycerol phenylbutyrate) and Buphenyl (sodium phenylbutyrate), which are used to treat urea cycle disorder. mark for My Articles 53 similar articles
Chemistry World
April 2, 2015
Emma Stoye
Novartis accused of 'derailing' trials for cheap eye disease drug The British Medical Journal has accused pharmaceutical giant Novartis of deliberately hindering research into the use of anticancer drug Avastin (bevacizumab) to treat age-related wet macular degeneration. mark for My Articles 140 similar articles
Information Today
April 2, 2015
Society of Interventional Radiology Chooses Thieme as Publishing Partner The plan is to publish several books each year about topics in the interventional radiology field. mark for My Articles 4 similar articles
Chemistry World
April 1, 2015
Sanjay Kumar
Sun Pharma snares Ranbaxy in $4bn deal Sun Pharma is now the fifth largest generics drug company in the world. mark for My Articles 132 similar articles
Chemistry World
April 1, 2015
Emma Stoye
Teva buys Auspex Pharmaceuticals for $3.2bn In a bid to strengthen its position in central nervous system R&D, one of its core therapeutic areas, generics giant Teva is set to acquire US-based biotech firm Auspex Pharmaceuticals. mark for My Articles 63 similar articles
HBS Working Knowledge
April 1, 2015
Carmen Nobel
The Slow, Steady Battle to Fix Cancer Care Thomas Feeley is on a quest to make payment procedures for cancer patients easier, hopefully less expensive, and in the process help change how health care is delivered in America. mark for My Articles 300 similar articles
CRM
April 2015
Leonard Klie
VoltDelta Is the Right Prescription for Rx Outreach The multichannel cloud contact center solution provides IVR, agent infrastructure, and automated prescription reminders for a mail-order pharmacy. mark for My Articles 36 similar articles
CRM
April 2015
Oren Smilansky
Athenahealth Increases Engagement with Force Management's QStream Platform The learning-based gamification program teaches reps better sales techniques. mark for My Articles 147 similar articles
Chemistry World
March 25, 2015
Phillip Broadwith
Valeant heads off Endo bid for Salix Valeant has flexed its acquisitive muscles to head off a rival bid for gastroenterology specialist Salix Pharmaceuticals. mark for My Articles 49 similar articles
<Older 9071-9080 Newer>    Return to current articles.